Silence Therapeutics Plc American Depository Share (SLN) is a publicly traded Healthcare sector company. As of July 17, 2026, SLN trades at $10.85 with a market cap of $493.60M and a P/E ratio of -19.29. SLN moved +4.45% today. Year to date, SLN is +79.61%; over the trailing twelve months it is +71.97%. Its 52-week range spans $1.97 to $11.06. Analyst consensus is strong buy with an average price target of $42.33. Rallies surfaces SLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SLN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $10.85 |
| Market Cap | $493.60M |
| P/E Ratio | -19.29 |
| EPS | $-0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.06 |
| 52-Week Low | $1.97 |
| Volume | 547.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $839.00K |
| Net Income | $-75.04M |
| Gross Margin | 79.50% |
5 analysts cover SLN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.33.